• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用于缓释制剂体外-体内相关性的人工神经网络:初步试验与经验

Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience.

作者信息

Dowell J A, Hussain A, Devane J, Young D

机构信息

In Vitro-In Vivo Relationship Cooperative Working Group, Pharmacokinetics-Biopharmaceutics Laboratory, Department of Pharmaceutical Sciences, University of Maryland at Baltimore, Baltimore, Maryland 21201, USA.

出版信息

J Pharm Sci. 1999 Jan;88(1):154-60. doi: 10.1021/js970148p.

DOI:10.1021/js970148p
PMID:9874718
Abstract

Artificial neural networks applied to in vitro-in vivo correlations (ANN-IVIVC) have the potential to be a reliable predictive tool that overcomes some of the difficulties associated with classical regression methods, principally, that of providing an a priori specification of the regression equation structure. A number of unique ANN configurations are presented, that have been evaluated for their ability to determine an IVIVC from different formulations of the same product. Configuration variables included a combination of architectural structures, learning algorithms, and input-output association structures. The initial training set consisted of two formulations and included the dissolution from each of the six cells in the dissolution bath as inputs, with associated outputs consisting of 1512 pharmacokinetic time points from nine patients enrolled in a crossover study. A third formulation IVIVC data set was used for predictive validation. Using these data, a total of 29 ANN configurations were evaluated. The ANN structures included the traditional feed forward, recurrent, jump connections, and general regression neural networks, with input-output association types consisting of the direct mapping of the dissolution profiles to the pharmacokinetic observations, mapping the individual dissolution points to the individual observations, and using a "memorative" input-output association. The ANNs were evaluated on the basis of their predictive performance, which was excellent for some of these ANN models. This work provides a basic foundation for ANN-IVIVC modeling and is the basis for continued modeling with other desirable inputs, such as formulation variables and subject demographics.

摘要

应用于体外-体内相关性(ANN-IVIVC)的人工神经网络有潜力成为一种可靠的预测工具,它能克服一些与经典回归方法相关的困难,主要是为回归方程结构提供先验规范这一困难。本文介绍了多种独特的人工神经网络配置,并对它们从同一产品的不同剂型确定体外-体内相关性的能力进行了评估。配置变量包括架构结构、学习算法和输入-输出关联结构的组合。初始训练集由两种剂型组成,包括溶出度试验中六个溶出杯各自的溶出度作为输入,相关输出由参与交叉研究的九名患者的1512个药代动力学时间点组成。第三个剂型的体外-体内相关性数据集用于预测验证。利用这些数据,共评估了29种人工神经网络配置。人工神经网络结构包括传统的前馈、递归、跳跃连接和广义回归神经网络,输入-输出关联类型包括将溶出曲线直接映射到药代动力学观测值、将各个溶出点映射到各个观测值以及使用“记忆性”输入-输出关联。基于其预测性能对人工神经网络进行了评估,其中一些人工神经网络模型的预测性能非常出色。这项工作为体外-体内相关性人工神经网络建模提供了基础,也是使用其他理想输入(如剂型变量和受试者人口统计学数据)继续建模的基础。

相似文献

1
Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience.应用于缓释制剂体外-体内相关性的人工神经网络:初步试验与经验
J Pharm Sci. 1999 Jan;88(1):154-60. doi: 10.1021/js970148p.
2
The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in vitro dissolution of sustained release minitablets.使用人工神经网络来选择最合适的制剂和工艺变量,以预测缓释微型片的体外溶出度。
AAPS PharmSciTech. 2003;4(2):E26. doi: 10.1208/pt040226.
3
An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation.广义回归神经网络分析在建立A级体外-体内相关性中的应用研究。
Eur J Pharm Sci. 2007 Mar;30(3-4):264-72. doi: 10.1016/j.ejps.2006.11.010. Epub 2006 Nov 19.
4
Comparison of four artificial neural network software programs used to predict the in vitro dissolution of controlled-release tablets.用于预测控释片体外溶出度的四种人工神经网络软件程序的比较。
Pharm Dev Technol. 2002;7(3):373-9. doi: 10.1081/pdt-120005733.
5
The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms.人工神经网络和药代动力学模拟在控释剂型设计中的应用。
J Control Release. 1999 May 1;59(1):33-41. doi: 10.1016/s0168-3659(98)00171-0.
6
Artificial neural networks in the optimization of a nimodipine controlled release tablet formulation.人工神经网络在尼莫地平控释片制剂优化中的应用。
Eur J Pharm Biopharm. 2010 Feb;74(2):316-23. doi: 10.1016/j.ejpb.2009.09.011. Epub 2009 Oct 6.
7
Use of an artificial neural network to predict head injury outcome.利用人工神经网络预测颅脑损伤结局。
J Neurosurg. 2010 Sep;113(3):585-90. doi: 10.3171/2009.11.JNS09857.
8
In vitro--in silico--in vivo drug absorption model development based on mechanistic gastrointestinal simulation and artificial neural networks: nifedipine osmotic release tablets case study.基于胃肠道机制模拟和人工神经网络的体外-计算机模拟-体内药物吸收模型开发:硝苯地平渗透释放片案例研究
Eur J Pharm Sci. 2014 Oct 1;62:212-8. doi: 10.1016/j.ejps.2014.05.030. Epub 2014 Jun 6.
9
Prediction of dissolution profiles of acetaminophen beads using artificial neural networks.使用人工神经网络预测对乙酰氨基酚微丸的溶出曲线。
Pharm Dev Technol. 2006;11(3):337-49. doi: 10.1080/10837450600769744.
10
In vitro - in vivo correlation: from theory to applications.体外-体内相关性:从理论到应用
J Pharm Pharm Sci. 2006;9(2):169-89.

引用本文的文献

1
Current Challenges to Align Inflammatory Key Events in Animals and Lung Cell Models .当前在动物和肺细胞模型中调整炎症关键事件所面临的挑战。
Chem Res Toxicol. 2024 Oct 21;37(10):1601-1611. doi: 10.1021/acs.chemrestox.4c00113. Epub 2024 Aug 8.
2
Machine Learning-Enabled NIR Spectroscopy. Part 3: Hyperparameter by Design (HyD) Based ANN-MLP Optimization, Model Generalizability, and Model Transferability.基于机器学习的近红外光谱技术。第3部分:基于设计超参数(HyD)的人工神经网络-多层感知器优化、模型通用性和模型可转移性。
AAPS PharmSciTech. 2023 Dec 7;24(8):254. doi: 10.1208/s12249-023-02697-3.
3
State-of-the-Art Review of Artificial Neural Networks to Predict, Characterize and Optimize Pharmaceutical Formulation.
用于预测、表征和优化药物制剂的人工神经网络的最新综述
Pharmaceutics. 2022 Jan 13;14(1):183. doi: 10.3390/pharmaceutics14010183.
4
and correlation for lipid-based formulations: Current status and future perspectives.基于脂质的制剂的相关性:现状与未来展望。
Acta Pharm Sin B. 2021 Aug;11(8):2469-2487. doi: 10.1016/j.apsb.2021.03.025. Epub 2021 Mar 21.
5
Pivotal Role of Quantum Dots in the Advancement of Healthcare Research.量子点在推动医疗保健研究中的关键作用。
Comput Intell Neurosci. 2021 Aug 6;2021:2096208. doi: 10.1155/2021/2096208. eCollection 2021.
6
Bioavailability, bioequivalence, and in vitro-in vivo correlation of oxybutynin transdermal patch in rabbits.奥昔布宁透皮贴片在兔体内的生物利用度、生物等效性和体外-体内相关性。
Drug Deliv Transl Res. 2014 Apr;4(2):105-15. doi: 10.1007/s13346-013-0170-y.
7
In vitro- in vivo correlation's dissolution limits setting.体外-体内相关性的溶出限度设定
Pharm Res. 2014 Sep;31(9):2529-38. doi: 10.1007/s11095-014-1349-8. Epub 2014 Mar 28.
8
Neuro-fuzzy models as an IVIVR tool and their applicability in generic drug development.神经模糊模型作为 IVIVR 工具及其在仿制药开发中的适用性。
AAPS J. 2014 Mar;16(2):324-34. doi: 10.1208/s12248-014-9569-8. Epub 2014 Jan 30.
9
Artificial neural networks in evaluation and optimization of modified release solid dosage forms.人工神经网络在改良释放固体制剂的评价和优化中的应用。
Pharmaceutics. 2012 Oct 18;4(4):531-50. doi: 10.3390/pharmaceutics4040531.
10
Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks.基于人工神经网络的广义体外-体内关系(IVIVR)模型
Drug Des Devel Ther. 2013;7:223-32. doi: 10.2147/DDDT.S41401. Epub 2013 Mar 27.